Productively infected murine Kaposi's sarcoma-like tumors define new animal models for studying and targeting KSHV oncogenesis and replication

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  Ashlock, Brittany M ^a   Ma, Qi ^a   Issac, Biju ^a   Mesri, Enrique A ^a  

^a UNIVERSITY OF MIAMI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VORINOSTAT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; CANCER STEM CELL; CELL ISOLATION; CONTROLLED STUDY; HUMAN HERPESVIRUS 8; IMMUNOCOMPROMISED PATIENT; IN VIVO STUDY; KAPOSI SARCOMA; MOUSE; MURINE MODEL; NONHUMAN; SPINDLE CELL; VIRION; VIRUS CARCINOGENESIS; VIRUS CELL INTERACTION; VIRUS REACTIVATION; VIRUS REPLICATION;

ANIMALS; BONE MARROW CELLS; CARCINOGENESIS; CELL CULTURE TECHNIQUES; DISEASE MODELS, ANIMAL; HERPESVIRUS 8, HUMAN; IMMUNOCOMPROMISED HOST; MICE; SARCOMA, KAPOSI;

EID: 84900315046     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0087324     Document Type: Article

References (62)

1. Sternbach G, Varon J (1995) Moritz Kaposi: idiopathic pigmented sarcoma of the skin. J Emerg Med 13: 671-674.
2. Ganem D (2006) KSHV infection and the pathogenesis of Kaposi's sarcoma. Annu Rev Pathol 1: 273-296.
3. Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, et al. (1994) Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 266: 1865-1869.
4. Gottlieb GJ, Ragaz A, Vogel JV, Friedman-Kien A, Rywlin AM, et al. (1981) A preliminary communication on extensively disseminated Kaposi's sarcoma in young homosexual men. Am J Dermatopathol 3: 111-114. (Pubitemid 11043360)
5. Nador RG, Cesarman E, Chadburn A, Dawson DB, Ansari MQ, et al. (1996) Primary effusion lymphoma: a distinct clinicopathologic entity associated with the Kaposi's sarcoma-associated herpes virus. Blood 88: 645-656. (Pubitemid 26240396)
6. Soulier J, Grollet L, Oksenhendler E, Cacoub P, Cazals-Hatem D, et al. (1995) Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease. Blood 86: 1276-1280.
7. Grayson W, Pantanowitz L (2008) Histological variants of cutaneous Kaposi sarcoma. Diagn Pathol 3: 31.
8. Simonart T, Hermans P, Schandene L, Van Vooren JP (2000) Phenotypic characteristics of Kaposi's sarcoma tumour cells derived from patch-, plaqueand nodular-stage lesions: analysis of cell cultures isolated from AIDS and non-AIDS patients and review of the literature. Br J Dermatol 143: 557-563.
9. Cancian L, Hansen A, Boshoff C (2013) Cellular origin of Kaposi's sarcoma and Kaposi's sarcoma-associated herpesvirus-induced cell reprogramming. Trends Cell Biol 23: 421-432.
10. Mesri EA, Cesarman E, Boshoff C (2010) Kaposi's sarcoma and its associated herpesvirus. Nature reviews Cancer 10: 707-719.
11. Parsons CH, Szomju B, Kedes DH (2004) Susceptibility of human fetal mesenchymal stem cells to Kaposi sarcoma-associated herpesvirus. Blood 104: 2736-2738. (Pubitemid 39434955)
12. Ganem D (2010) KSHV and the pathogenesis of Kaposi sarcoma: listening to human biology and medicine. J Clin Invest 120: 939-949.
13. Della Bella S, Taddeo A, Calabro ML, Brambilla L, Bellinvia M, et al. (2008) Peripheral blood endothelial progenitors as potential reservoirs of Kaposi's sarcoma-associated herpesvirus. PLoS One 3: e1520.
14. Mesri EA, Cesarman E, Boshoff C (2010) Kaposi's sarcoma and its associated herpesvirus. Nat Rev Cancer 10: 707-719.
15. Ma T, Jham BC, Hu J, Friedman ER, Basile JR, et al. (2010) Viral G protein-coupled receptor up-regulates Angiopoietin-like 4 promoting angiogenesis and vascular permeability in Kaposi's sarcoma. Proceedings of the National Academy of Sciences of the United States of America 107: 14363-14368.
16. Choi YB, Nicholas J (2008) Autocrine and paracrine promotion of cell survival and virus replication by human herpesvirus 8 chemokines. Journal of virology 82: 6501-6513.
17. Maskew M, Fox MP, van Cutsem G, Chu K, Macphail P, et al. (2013) Treatment response and mortality among patients starting antiretroviral therapy with and without Kaposi sarcoma: a cohort study. PLoS One 8: e64392.
18. Cooley T, Henry D, Tonda M, Sun S, O9Connell M, et al. (2007) A randomized, double-blind study of pegylated liposomal doxorubicin for the treatment of AIDS-related Kaposi's sarcoma. Oncologist 12: 114-123. (Pubitemid 46143509)
19. Cattelan AM, Trevenzoli M, Aversa SM (2002) Recent advances in the treatment of AIDS-related Kaposi's sarcoma. Am J Clin Dermatol 3: 451-462. (Pubitemid 35007063)
20. Sullivan RJ, Pantanowitz L, Dezube BJ (2009) Targeted therapy for Kaposi sarcoma. BioDrugs 23: 69-75.
21. Nguyen HQ, Magaret AS, Kitahata MM, Van Rompaey SE, Wald A, et al. (2008) Persistent Kaposi sarcoma in the era of highly active antiretroviral therapy: characterizing the predictors of clinical response. AIDS 22: 937-945. (Pubitemid 351652244)
22. Ganem D (2010) KSHV and the pathogenesis of Kaposi sarcoma: listening to human biology and medicine. The Journal of clinical investigation 120: 939-949.
23. Lee HR, Brulois K, Wong L, Jung JU (2012) Modulation of Immune System by Kaposi's Sarcoma-Associated Herpesvirus: Lessons from Viral Evasion Strategies. Front Microbiol 3: 44.
24. Ballestas ME, Chatis PA, Kaye KM (1999) Efficient persistence of extrachromosomal KSHV DNA mediated by latency-associated nuclear antigen. Science 284: 641-644. (Pubitemid 29289588)
25. Paul AG, Sharma-Walia N, Chandran B (2011) Targeting KSHV/HHV-8 latency with COX-2 selective inhibitor nimesulide: a potential chemotherapeutic modality for primary effusion lymphoma. PLoS One 6: e24379.
26. Contreras X, Schweneker M, Chen CS, McCune JM, Deeks SG, et al. (2009) Suberoylanilide hydroxamic acid reactivates HIV from latently infected cells. The Journal of biological chemistry 284: 6782-6789.
27. Ghosh SK, Perrine SP, Williams RM, Faller DV (2012) Histone deacetylase inhibitors are potent inducers of gene expression in latent EBV and sensitize lymphoma cells to nucleoside antiviral agents. Blood 119: 1008-1017.
28. Mutlu AD, Cavallin LE, Vincent L, Chiozzini C, Eroles P, et al. (2007) In vivo-restricted and reversible malignancy induced by human herpesvirus-8 KSHV: a cell and animal model of virally induced Kaposi's sarcoma. Cancer cell 11: 245-258. (Pubitemid 46357638)
29. Staudt MR, Kanan Y, Jeong JH, Papin JF, Hines-Boykin R, et al. (2004) The tumor microenvironment controls primary effusion lymphoma growth in vivo. Cancer Res 64: 4790-4799. (Pubitemid 38924522)
30. Myoung J, Ganem D (2011) Generation of a doxycycline-inducible KSHV producer cell line of endothelial origin: maintenance of tight latency with efficient reactivation upon induction. J Virol Methods 174: 12-21.
31. Austgen K, Oakes SA, Ganem D (2012) Multiple defects, including premature apoptosis, prevent Kaposi's sarcoma-associated herpesvirus replication in murine cells. J Virol 86: 1877-1882.
32. Casper C, Krantz EM, Corey L, Kuntz SR, Wang J, et al. (2008) Valganciclovir for suppression of human herpesvirus-8 replication: a randomized, double-blind, placebo-controlled, crossover trial. J Infect Dis 198: 23-30. (Pubitemid 351920285)
33. Casper C, Nichols WG, Huang ML, Corey L, Wald A (2004) Remission of HHV-8 and HIV-associated multicentric Castleman disease with ganciclovir treatment. Blood 103: 1632-1634. (Pubitemid 38268952)
34. Martin DF, Kuppermann BD, Wolitz RA, Palestine AG, Li H, et al. (1999) Oral ganciclovir for patients with cytomegalovirus retinitis treated with a ganciclovir implant. Roche Ganciclovir Study Group. The New England journal of medicine 340: 1063-1070. (Pubitemid 29162510)
35. Bhatt S, Ashlock BM, Toomey NL, Diaz LA, Mesri EA, et al. (2013) Efficacious proteasome/HDAC inhibitor combination therapy for primary effusion lymphoma. The Journal of clinical investigation 123: 2616-2628.
36. Picchio GR, Sabbe RE, Gulizia RJ, McGrath M, Herndier BG, et al. (1997) The KSHV/HHV8-infected BCBL-1 lymphoma line causes tumors in SCID mice but fails to transmit virus to a human peripheral blood mononuclear cell graft. Virology 238: 22-29. (Pubitemid 27497258)
37. Dittmer D, Stoddart C, Renne R, Linquist-Stepps V, Moreno ME, et al. (1999) Experimental transmission of Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) to SCID-hu Thy/Liv mice. J Exp Med 190: 1857-1868. (Pubitemid 30013851)
38. Wu W, Vieira J, Fiore N, Banerjee P, Sieburg M, et al. (2006) KSHV/HHV-8 infection of human hematopoietic progenitor (CD34+) cells: persistence of infection during hematopoiesis in vitro and in vivo. Blood 108: 141-151. (Pubitemid 43990622)
39. Chang H, Wachtman LM, Pearson CB, Lee JS, Lee HR, et al. (2009) Non-human primate model of Kaposi's sarcoma-associated herpesvirus infection. PLoS Pathog 5: e1000606.
40. Jones T, Ye F, Bedolla R, Huang Y, Meng J, et al. (2012) Direct and efficient cellular transformation of primary rat mesenchymal precursor cells by KSHV. The Journal of clinical investigation 122: 1076-1081.
41. Zhou FC, Zhang YJ, Deng JH, Wang XP, Pan HY, et al. (2002) Efficient infection by a recombinant Kaposi's sarcoma-associated herpesvirus cloned in a bacterial artificial chromosome: application for genetic analysis. J Virol 76: 6185-6196.
42. Vieira J, O'Hearn PM (2004) Use of the red fluorescent protein as a marker of Kaposi's sarcoma-associated herpesvirus lytic gene expression. Virology 325: 225-240.
43. Bogoslovsky T, Chaudhry A, Latour L, Maric D, Luby M, et al. (2010) Endothelial progenitor cells correlate with lesion volume and growth in acute stroke. Neurology 75: 2059-2062.
44. Salven P, Mustjoki S, Alitalo R, Alitalo K, Rafii S (2003) VEGFR-3 and CD133 identify a population of CD34+ lymphatic/vascular endothelial precursor cells. Blood 101: 168-172. (Pubitemid 36025904)
45. Liu R, Li X, Tulpule A, Zhou Y, Scehnet JS, et al. (2010) KSHV-induced notch components render endothelial and mural cell characteristics and cell survival. Blood 115: 887-895.
46. Moses AV, Fish KN, Ruhl R, Smith PP, Strussenberg JG, et al. (1999) Long-term infection and transformation of dermal microvascular endothelial cells by human herpesvirus 8. Journal of virology 73: 6892-6902. (Pubitemid 29327872)
47. Leung HJ, Duran EM, Kurtoglu M, Andreansky S, Lampidis TJ, et al. (2012) Activation of the unfolded protein response by 2-deoxy-D-glucose inhibits Kaposi's sarcoma-associated herpesvirus replication and gene expression. Antimicrob Agents Chemother 56: 5794-5803.
48. Zhou FC, Zhang YJ, Deng JH, Wang XP, Pan HY, et al. (2002) Efficient infection by a recombinant Kaposi's sarcoma-associated herpesvirus cloned in a bacterial artificial chromosome: application for genetic analysis. Journal of virology 76: 6185-6196.
49. Krishnan HH, Sharma-Walia N, Zeng L, Gao SJ, Chandran B (2005) Envelope glycoprotein gB of Kaposi's sarcoma-associated herpesvirus is essential for egress from infected cells. Journal of virology 79: 10952-10967. (Pubitemid 41170637)
50. Yakushko Y, Hackmann C, Gunther T, Ruckert J, Henke M, et al. (2011) Kaposi's sarcoma-associated herpesvirus bacterial artificial chromosome contains a duplication of a long unique-region fragment within the terminal repeat region. Journal of virology 85: 4612-4617.
51. Austgen K, Oakes SA, Ganem D (2012) Multiple defects, including premature apoptosis, prevent Kaposi's sarcoma-associated herpesvirus replication in murine cells. Journal of virology 86: 1877-1882.
52. Parsons CH, Adang LA, Overdevest J, O9Connor CM, Taylor JRJ, et al. (2006) KSHV targets multiple leukocyte lineages during long-term productive infection in NOD/SCID mice. The Journal of clinical investigation 116: 1963-1973. (Pubitemid 44033320)
53. Yu X, Lin Y, Yan X, Tian Q, Li L, et al. (2011) CD133, Stem Cells, and Cancer Stem Cells: Myth or Reality? Curr Colorectal Cancer Rep 7: 253-259.
54. Fonseca AV, Bauer N, Corbeil D (2008) The stem cell marker CD133 meets the endosomal compartment-new insights into the cell division of hematopoietic stem cells. Blood Cells Mol Dis 41: 194-195.
55. Hong YK, Foreman K, Shin JW, Hirakawa S, Curry CL, et al. (2004) Lymphatic reprogramming of blood vascular endothelium by Kaposi sarcoma-associated herpesvirus. Nat Genet 36: 683-685. (Pubitemid 38886627)
56. Wang HW, Trotter MW, Lagos D, Bourboulia D, Henderson S, et al. (2004) Kaposi sarcoma herpesvirus-induced cellular reprogramming contributes to the lymphatic endothelial gene expression in Kaposi sarcoma. Nat Genet 36: 687-693. (Pubitemid 38886628)
57. Cornali E, Zietz C, Benelli R, Weninger W, Masiello L, et al. (1996) Vascular endothelial growth factor regulates angiogenesis and vascular permeability in Kaposi's sarcoma. Am J Pathol 149: 1851-1869. (Pubitemid 26415207)
58. Carroll PA, Brazeau E, Lagunoff M (2004) Kaposi's sarcoma-associated herpesvirus infection of blood endothelial cells induces lymphatic differentiation. Virology 328: 7-18. (Pubitemid 39221907)
59. Orenstein JM, Alkan S, Blauvelt A, Jeang KT, Weinstein MD, et al. (1997) Visualization of human herpesvirus type 8 in Kaposi's sarcoma by light and transmission electron microscopy. AIDS 11: F35-45. (Pubitemid 27135875)
60. Fu DX, Tanhehco Y, Chen J, Foss CA, Fox JJ, et al. (2008) Bortezomib-induced enzyme-targeted radiation therapy in herpesvirus-associated tumors. Nat Med 14: 1118-1122.
61. Perrine SP, Hermine O, Small T, Suarez F, O9Reilly R, et al. (2007) A phase 1/2 trial of arginine butyrate and ganciclovir in patients with Epstein-Barr virus-associated lymphoid malignancies. Blood 109: 2571-2578. (Pubitemid 46425904)
62. Johnson WE, Li C, Rabinovic A (2007) Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics 8: 118-127. (Pubitemid 44906106)